Telangiectasia in Systemic Sclerosis Is a Marker of Increased Disease Morbidity and Mortality: Analyses From the Australian Scleroderma Cohort Study
Australasian Journal of Dermatology · 2026-11 · 67 (7)
DOI: 10.1111/ajd.70179 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Australasian Journal of Dermatology, online erschienen am 06.07.2026. Verfasst von Vivien Wai Yun Lai und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Royal Melbourne Hospital, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Telangiectasis, Hypertension, Pulmonary. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Australian Scleroderma Interest Group.
Abstract (Originalsprache)
This Australian retrospective cohort analysis of 1977 patients investigates and expands on correlates of telangiectasia in systemic sclerosis to determine whether this cutaneous sign is a potential surrogate marker for disease progression and prognosis. We found that pulmonary arterial hypertension and digital ulcers were significant correlates of telangiectasia, which was also an independent risk factor for mortality. Careful monitoring of telangiectasia may provide an indicator for more severe vasculopathy, with increased morbidity and mortality in systemic sclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
- The University of Melbourne, St. Vincent's Hospital, Melbourne, Melbourne, Victoria, Australia.
- Department of Rheumatology, St Vincent's Hospital, Melbourne, Melbourne, Victoria, Australia.
- Department of Rheumatology, Monash Medical Centre, Melbourne, Victoria, Australia.
- Department of Medicine, Monash University, Melbourne, Victoria, Australia.
- Department of Rheumatology, Fiona Stanley Hospital, Perth, Western Australia, Australia.
ORCID-Profile: Vivien Wai Yun Lai, Jessica Fairley, Laura Ross, Gabor Major, Amanda M Saracino
Förderung
- Australian Scleroderma Interest Group
Zitieren
APA
Lai, V. W. Y., Hansen, D., Tabesh, M., Fairley, J., Ross, L., Ferdowsi, N., Ngian, G. S., Apostolopoulos, D., Sahhar, J., Host, L. V., Walker, J., Major, G., Proudman, S., Stevens, W., Nikpour, M., & Saracino, A. M. (2026). Telangiectasia in Systemic Sclerosis Is a Marker of Increased Disease Morbidity and Mortality: Analyses From the Australian Scleroderma Cohort Study. Australasian Journal of Dermatology, 67(7). https://doi.org/10.1111/ajd.70179
Vancouver
Lai VWY, Hansen D, Tabesh M, Fairley J, Ross L, Ferdowsi N, et al. Telangiectasia in Systemic Sclerosis Is a Marker of Increased Disease Morbidity and Mortality: Analyses From the Australian Scleroderma Cohort Study. Australasian Journal of Dermatology. 2026;67(7). doi:10.1111/ajd.70179
BibTeX
@article{Lai2026,
author = {Lai, Vivien Wai Yun and Hansen, Dylan and Tabesh, Maryam and Fairley, Jessica and Ross, Laura and Ferdowsi, Nava and Ngian, Gene-Siew and Apostolopoulos, Diane and Sahhar, Joanne and Host, Lauren V and Walker, Jennifer and Major, Gabor and Proudman, Susanna and Stevens, Wendy and Nikpour, Mandana and Saracino, Amanda M},
title = {Telangiectasia in Systemic Sclerosis Is a Marker of Increased Disease Morbidity and Mortality: Analyses From the Australian Scleroderma Cohort Study},
journal = {Australasian Journal of Dermatology},
year = {2026},
volume = {67},
number = {7},
doi = {10.1111/ajd.70179}
}
EUVIMED